SC 13D

Company

NEUROCRINE BIOSCIENCES INC

Filed

December 11, 2019

Accession Number

0001564590-19-045741

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →